跳至主要内容
临床试验/RBR-2fm8j9
RBR-2fm8j9进行中(未招募)未知

Role of the Intestinal Microbiota for management of Metabolic syndrome and Obesity - : Clinics Hospital of Univesity of Sao Paulo

Faculdade de Medicina da Universidade São Paulo0 个研究点开始时间: 2019年10月22日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 75Y(—)
性别
Female

入选标准

  • Receivers: Caucasian women between the ages of 18 and 60 with a Body Mass Index (BMI) between 30 and 40 kg / m2 - obesity grade I and II - who meet the 2005 International Diabetes Federation (IDF) criteria for metabolic syndrome.

排除标准

  • Receptors: patients with comorbidities that may interfere with data evaluation, use medications for metabolic syndrome, use antibiotics / pro-biotics in the past 90 days, previous cholecystectomy surgery, or have recent weight changes. Patients who refuse to participate in the study or who do not sign any of the terms of consent will also be excluded.
  • Donors: donors who have received antibiotics for the last three months, who have risky sexual behavior

研究者

发起方
Faculdade de Medicina da Universidade São Paulo

相似试验

The role of intestinal bacteria in obese patients... | 临床试验